How Pharma R&D Functions Can Best Tap Bioplatforms

With the explosion of different modalities and the incredible speed and potential of the AI/ML revolution, partnerships between platform companies and larger pharma are more critical than ever to accelerate drug development. John Lepore, CEO of ProFound Therapeutics and CEO-Partner, Flagship Pioneering, Mike Nally, CEO of Generate:Biomedicines and CEO-Partner, Flagship Pioneering, and Luciano Rossetti, Chief Medical Officer, Flagship Pioneering and Head of Research & Development, Pioneering Medicines join Amanda Kay, Chief Business Development Officer and Senior Partner, Flagship Pioneering to discuss the opportunity that Flagship’s innovative bioplatforms offer in terms of novel partnerships with pharma to bring about new therapeutics. More from Flagship @ JPM2024 here.